deucravacitinib,apremilast
bms,amgen
[]
excellent coverage of the major win for allosteric tyk2s last night w sotyktu s approval in the us 
CEO @NimbusTx. A guy (he/him) helping teams discover and develop new medicines for patients. Any tweets are solely my own personal views.